Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$1.48 USD
-0.03 (-1.99%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.45 -0.03 (-2.03%) 6:12 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Corvus Pharmaceuticals (CRVS) reported earnings of -$0.14 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for CRVS's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 29.41%.
Earnings History
Price & Consensus
Zacks News for CRVS
Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
CRVS: What are Zacks experts saying now?
Zacks Private Portfolio Services